Sign In
Buy BSX
$47.69
+0.0100 (+0.0210%)
At Close: Jun 03, 2026
Boston Scientific (BSX) Down 2.1% Since Last Earnings Report: Can It Rebound?
12:11pm, Friday, 05'th Mar 2021
Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock?
Baring Private Equity Asia Announces Agreement to Sell Lumenis' Surgical Business to Boston Scientific for USD1.07 billion
02:04pm, Wednesday, 03'rd Mar 2021
YOKNEAM, Israel and HONG KONG, March 3, 2021 /PRNewswire/ -- Baring Private Equity Asia (BPEA) and Lumenis announced today that they have entered into a definitive agreement to sell the Lumenis Surgic
Boston Scientific to spend $1.1 billion in cash to buy Lumentis LTD's surgical business
07:00am, Wednesday, 03'rd Mar 2021
Boston Scientific Corp. announced Wednesday an agreement to buy the global surgical business of Lumenis LTD for $1.07 billion in cash from Baring Private Equity Asia. The medical technology company sa
7 Stocks to Sell for March
01:16pm, Friday, 26'th Feb 2021
The market is starting to get volatile again and sector rotation is underway. Clear the decks by dumping these stocks to sell for March.
Henry Schein Likely To Offer Better Returns Compared To Boston Scientific Stock
07:00am, Wednesday, 24'th Feb 2021
We think that Henry Schein currently is a better pick compared to Boston Scientific. HSIC stock trades at about 0.9x trailing Revenues, compared to around 5.5x for Boston Scientific.
14 AI Stocks to Stay Away From
05:56pm, Tuesday, 16'th Feb 2021
Whether in transportation, manufacturing or healthcare, don't touch any of these 14 AI-related stocks with a 10-foot pole. Here's why.
Boston Scientific Announces February and March 2021 Conference Schedule
09:30am, Friday, 12'th Feb 2021
MARLBOROUGH, Mass., Feb. 12, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences. On February 25, 2021, Dan Brennan, executive vice pre
Boston Scientific (BSX) Hurt by Product Recall, Conversion
10:37am, Tuesday, 09'th Feb 2021
Barring MedSurg, organic revenues at each of Boston Scientific (BSX) core segments and geographies are down in Q4 but the magnitude of this decline is lower than Q3.
Boston Scientific Corporation (BSX) CEO Michael Mahoney on Q4 2020 Results - Earnings Call Transcript
12:36pm, Wednesday, 03'rd Feb 2021
Boston Scientific Corporation (BSX) CEO Michael Mahoney on Q4 2020 Results - Earnings Call Transcript
Boston Scientific (BSX) Q4 Earnings Miss, Margins Decline
11:22am, Wednesday, 03'rd Feb 2021
Apart from a drop in Q4 earnings and revenues drop year over year, Boston Scientific (BSX) also registers strong sequential decline in overall financial performance.
Boston Scientific (BSX) Q4 Earnings and Revenues Lag Estimates
09:06am, Wednesday, 03'rd Feb 2021
Boston Scientific (BSX) delivered earnings and revenue surprises of -25.81% and -0.02%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Recap: Boston Scientific Q4 Earnings
07:23am, Wednesday, 03'rd Feb 2021
Shares of Boston Scientific (NYSE:BSX) fell 2.0% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreased 50.00% year over year to $0.23, which misse
Boston Scientific stock falls after profit and sales miss, downbeat outlook
06:48am, Wednesday, 03'rd Feb 2021
Shares of Boston Scientific Corp. dropped 3.2% in premarket trading Wednesday, after the medical technology company reported fourth-quarter profit and revenue that fell more than expected, and provide
Boston Scientific Announces Results For Fourth Quarter And Full Year 2020
06:30am, Wednesday, 03'rd Feb 2021
MARLBOROUGH, Mass., Feb. 3, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.708 billion during the fourth quarter of 2020. This represents a decline of (6.8) p
LOS ANGELES--(BUSINESS WIRE)---- $BSX #BSX--DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Boston Scientific Corporation
